Platelet rich plasma therapy, also known simply as pleronic rich plasma therapy, is a medical treatment in which a patient’s blood is centrifugated and treated with high-pressure sodium salt solution in the absence of blood cells (red blood cells). The blood is usually drawn four hours before bedtime. In addition, patients are required to fast for three hours after receiving the medicine. The medicine is taken in three doses, with one additional medication for cats at a later stage. This treatment relieves the patients of constipation, diarrhea and reduces the need for antibiotics. Although this form of treatment is relatively new, there are now many researchers who believe that it has positive benefits.
The global platelet-rich plasma market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/936
Competitive Landscape:
Major players operating in the global platelet-rich plasma market include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd.
Market Drivers:
Growing number of cosmetic surgeries is expected to foster growth of the platelet-rich plasma market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) around 1,036,618 cosmetic procedures were carried out in Mexico and nearly 128,398 procedures in Thailand in 2018.
Additionally, high prevalence of sports injuries is again expected to support growth of the global platelet-rich plasma market in the near future. For instance, according to the National High School Sports-Related Injury Surveillance Study 2017-2018, 1,367,490 cases of sport-related were recorded in high schools in the U.S.
Statistics:
Pure PRP held leading position in the global platelet-rich plasma market in 2019, accounting for 40.9% share in terms of value, followed by Leukocyte rich PRP and Pure PRF, respectively.
Market Restraints:
Factor such as uncertainty regarding therapeutic efficacy of platelet-rich plasma is expected to restrict growth of the global platelet-rich plasma market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.
Additionally, high cost of platelet-rich plasma products is also expected to hamper growth of the market. The average price of platelet-rich plasma injections starts from US$ 200 to US$ 800, based on its application areas. In addition, treatment of chronic diseases/injuries requires minimum three to six injections, which increases the overall cost of the treatment. Similarly, the average price of platelet-rich plasma centrifuge is around US$ 2,000 to US$ 15,000 (varies according to capacity and other parameters) and Platelet-rich plasma kit is around US$ 25 to US$ 200 (single use kit).
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/936
Market Opportunities:
R&D in drug delivery system for platelet-rich plasma-derived bioactive molecules is projected to provide lucrative growth opportunities for players in the global Platelet-rich plasma market. For instance, in September 2020, researchers from Institute of Experimental Medicine of the Czech Academy of Sciences and Charles University, Czech Republic, reported development of a simple delivery system to prolong the effects of the bioactive molecules released from platelets.
Also, high prevalence of musculoskeletal injuries is againg expected to boost growth of the global platelet-rich plasma market. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).
Market Trends/Key Takeaways
There is a high prevalence of alopecia around the globe which is projected to boost growth of the global platelet-rich plasma market. For instance, according to a 2019 survey released by the China Association of Health Promotion and Education (CAHEP), one out of six Chinese people, or about 250 million people, are suffering from hair loss.
Rapid adoption of platelet-rich plasma in cosmetic surgery is also expected to boost growth of the global Platelet-rich plasma market. For instance, according to the American Society of Plastic Surgeons (ASPS) reports platelet-rich plasma (PRP) treatment is estimated to increase by 12% from nearly 113,356 procedures in 2017 to approximately 127,394 procedures in 2018.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/936
Key Developments:
Major players in the global platelet-rich plasma market are focused on adopting partnership and collaboration strategies to enhance their market share. For instance, in March 2019, CollPlant, a regenerative medicine company, renewed its exclusive distribution agreement with Arthrex for Vergenix STR, an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous platelet-rich plasma, for the treatment of tendinopathy.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Origin
- Market Snippet, By Application
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Platelet Rich Plasma Market, By Type, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Pure PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Leukocyte rich PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Pure PRF
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Leukocyte rich PRF
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Platelet Rich Plasma Market, By Origin, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Allogenic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Homologues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Platelet Rich Plasma Market, By Application, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Cosmetic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Platelet Rich Plasma Market, By Regions, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Arthrex, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnsons Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet Holdings Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glofinn Oy
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medira Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regen Lab S.A
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies.
- CollPlant
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generex Biotechnology Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Estar Technologies Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Arthrex, Inc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com